Ebola gp-specific monoclonal antibodies protect mice and guinea pigs from lethal ebola virus infection

HIGHLIGHTS

• who: Ebola GP-Specific Monoclonal Antibodies et al. from the University of Manitoba, Winnipeg, Manitoba, Canada, Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada have published the research work: Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection, in the Journal: (JOURNAL) of March/20,/2012
• what: This study evaluates the protective efficacy of 8 (MAbs) against glycoprotein in and guinea pigs. The aim of this study was to test a panel of MAbs specific for the ZEBOV GP for their efficacy in protecting mice and guinea pigs . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.